Selenium, apoptosis, and colorectal adenomas

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 3, 2006, Pages 486-493

  Connelly Frost, Alexandra ^a,e   Poole, Charles ^a   Satia, Jessie A ^b,d   Kupper, Lawrence L ^d   Millikan, Robert C ^a   Sandler, Robert S ^a,c  

^a IL   (United States)

^b University of North Carolina   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d AMGEN INC   (United States)

^e R Stuart Dickson Institute for Health Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD LEVEL; CLINICAL PATHWAY; COLON CARCINOGENESIS; COLON CARCINOMA; COLONOSCOPY; COLORECTAL ADENOMA; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RECTUM BIOPSY; SELENIUM BLOOD LEVEL; SELENIUM DEFICIENCY;

ADENOMA; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOPSY, NEEDLE; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SELENIUM; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33645508277     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0759     Document Type: Article

References (67)

1. American Cancer Society. Cancer facts and figures, 2004. American Cancer Society, Inc.; 2004.
2. Reis LG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1975-2001. Bethesda (MD): National Cancer Institute.
3. Parkin DM. International variation. Oncogene 2004;23:6329-40.
4. Jansson B. Geographic mappings of colorectal cancer rates: a retrospect of studies, 1974-1984. Cancer Detect Prev 1985;8:341-8.
5. Boyle P, Zaridze DG. Colorectal cancer as a disease of the environment. Ecol Dis 1983;2:241-8.
6. Miller AB. Risk factors from geographic epidemiology for gastrointestinal cancer. Cancer 1982;50:2533-40.
7. Combs GF, Jr., Gray WP. Chemopreventive agents: selenium. Pharmacol Ther 1998;79:179-92.
8. Sunde RA. Selenium. In: Stipanuk M, editor. Biochemical and physiological aspects of human nutrition. London: W.B. Saunders Co.; 2000. p. 782-809.
9. Mason AC. Selenium. In: Smith KT, editor. Trace minerals in foods. New York: Basel; 1988. p. 325-55.
10. Alaejos MS, Diaz Romero FJ, Diaz RC. Selenium and cancer: some nutritional aspects. Nutrition 2000;16:376-83.
11. Fernandez-Banares F, Cabre E, Esteve M, et al. Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 2002;97:2103-8.
12. Schober SE, Comstock GW, Helsing KJ, et al. Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk. Am J Epidemiol 1987; 126:1033-41.
13. Mikac-Devic M, Vukelic N, Kljaic K. Serum selenium level in patients with colorectal cancer. Biol Trace Elem Res 1992;33:87-94.
14. Salonen JT, Alfthan G, Huttunen JK, Puska P. Association between serum selenium and the risk of cancer. Am J Epidemiol 1984;120:342-9.
15. Willett WC, Polk BF, Morris JS, et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983;2:130-4.
16. Nomura A, Heilbrun LK, Morris JS, Stemmermann GN. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J Natl Cancer Inst 1987;79:103-8.
17. Knekt P, Aromaa A, Maatela J, et al. Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int J Cancer 1988;42:846-50.
18. Nelson RL, Davis FG, Sutter E, et al. Serum selenium and colonic neoplastic risk. Dis Colon Rectum 1995;38:1306-10.
19. Garland M, Morris JS, Stampfer MJ, et al. Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 1995;87:497-505.
20. Ghadirian P, Maisonneuve P, Perret C, et al. A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev 2000;24:305-13.
21. Poole C. High dietary selenium intake and incidence of cancers of the lung, breast and large bowel [dissertation]. Boston: Harvard School of Public Health; 1989.
22. van den Brandt PA, Goldbohm RA, van't Veer, et al. A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. J Natl Cancer Inst 1993;85:224-9.
23. Clark LC, Combs GF, Jr., Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-63.
24. Ganther HE. Selenium metabolism and mechanisms of cancer prevention. Adv Exp Med Biol 2000;492:119-30.
25. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr 1998;128:1845-54.
26. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-6.
27. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
28. Kaufmann SH, Hengartner MO. Programmed cell death: alive and well in the new millennium. Trends Cell Biol 2001;11:526-34.
29. Que F, Gores GJ. Apoptosis and the gastrointestinal system. Adv Pharmacol 1997;41:409-28.
30. Sjostrom J, Bergh J. How apoptosis is regulated, and what goes wrong in cancer. BMJ 2001;322:1538-9.
31. Vander a, Sherman J, Luciano D. Human physiology: mechanisms of body function. 8th ed. New York: McGraw-Hill; 2001.
32. Wong BC, Zhu GH, Lam SK. Aspirin induced apoptosis in gastric cancer cells. Biomed Pharmacother 1999;53:315-8.
33. Martin C, Connelly A, Keku TO, et al. Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas. Gastroenterology 2002;123:1770-7.
34. Lanfear J, Fleming J, Wu L, Webster G, Harrison PR. The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 1994;15:1387-92.
35. Lu J, Kaeck M, Jiang C, Wilson AC, Thompson HJ. Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol 1994;47:1531-5.
36. Redman C, Xu MJ, Peng YM, et al. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis 1997;18:1195-202.
37. Redman C, Scott JA, Baines AT, et al. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett 1998;125:103-10.
38. Shen HM, Yang CF, Ong CN. Sodium selenite-induced oxidative stress and apoptosis in human hepatoma HepG2 cells. Int J Cancer 1999;81:820-8.
39. Stewart MS, Davis RL, Walsh LP, Pence BC. Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29). Cancer Lett 1997;117:35-40.
40. Stewart MS, Spallholz JE, Neldner KH, Pence BC. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 1999;26:42-8.
41. Waters DJ, Shen S, Cooley DM, et al. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J Natl Cancer Inst 2003;95:237-41.
42. Zhong W, Oberley TD. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 2001;61:7071-8.
43. Fleming J, Ghose A, Harrison PR. Molecular mechanisms of cancer prevention by selenium compounds. Nutr Cancer 2001;40:42-9.
44. Ghose A, Fleming J, El Bayoumy K, Harrison PR. Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways. Cancer Res 2001;61:7479-87.
45. Ip C, Dong Y, Ganther HE. New concepts in selenium chemoprevention. Cancer Metastasis Rev 2002;21:281-9.
46. Lu J. Apoptosis and angiogenesis in cancer prevention by selenium. Adv Exp Med Biol 2001;492:131-45.
47. Ghose A, Fleming J, Harrison PR. Selenium and signal transduction: roads to cell death and anti-tumour activity. Biofactors 2001;14:127-33.
48. Day DW, Morson BC. The adenoma-carcinoma sequence. Major Probl Pathol 1978;10:58-71.
49. Clark LC, Hixson LJ, Combs GF, Jr., Reid ME, Turnbull BW, Sampliner RE. Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 1993;2:41-6.
50. Russo MW, Murray SC, Wurzelmann JI, Woosley JT, Sandler RS. Plasma selenium levels and the risk of colorectal adenomas. Nutr Cancer 1997;28:125-9.
51. Wallace K, Byers T, Morris JS, et al. Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2003;12:464-7.
52. Dworkin BM, Rosenthal WS, Mittelman A, Weiss L, Applebee-Brady L, Arlin Z. Selenium status and the polyp-cancer sequence: a colonoscopically controlled study. Am J Gastroenterol 1988;83:748-51.
53. Early DS, Hill K, Burk R, Palmer I. Selenoprotein levels in patients with colorectal adenomas and cancer. Am J Gastroenterol 2002;97:745-8.
54. Block G, Hartman AM, Dresser CM, Carroll MD, Cannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-69.
55. Gerber AM, James SA, Ammerman AS, et al. Socioeconomic status and electrolyte intake in Black adults: the Pitt County Study. Am J Public Health 1991;81:1608-12.
56. Blair SN, Haskell WL, Ho P, et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 1985;122:794-804.
57. Jacobson BE, Lockitch G. Direct determination of selenium in serum by graphite-furnace atomic absorption spectrometry with deuterium background correction and a reduced palladium modifier: age-specific reference ranges. Clin Chem 1988;34:709-14.
58. Kok FJ, de Bruijn AM, Hofman A, Vermeeren R, Valkenburg HA. Is serum selenium a risk factor for cancer in men only? Am J Epidemiol 1987;125:12-6.
59. Food and Nutrition Board of the Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids: a report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and the Interpretation and Use of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Washington (DC): National Academy Press; 2000.
60. Niskar AS, Paschal DC, Kieszak SM, et al. Serum selenium levels in the US population: Third National Health and Nutrition Examination Survey, 1988-1994. Biol Trace Elem Res 2003;91:1-10.
61. Jacobs ET, Jiang R, Alberts DS, et al. Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst 2004;96:1669-75.
62. Combs GF, Jr. Considering the mechanisms of cancer prevention by selenium. Adv Exp Med Biol 2001;492:107-17.
63. Longtin R. Selenium for prevention: eating your way to better DNA repair? J Natl Cancer Inst 2003;95:98-100.
64. Thompson ML, Myers JE, Kriebel D. Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med 1998;55:272-7.
65. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003;20:21-33.
66. Skov T, Deddens J, Petersen MR, Endahl L. Prevalence proportion ratios: estimation and hypothesis testing. Int J Epidemiol 1998;27:91-5.
67. Schatzkin A, Gail M. The promise and peril of surrogate end points in cancer research. Nat Rev Cancer 2002;2:19-27.